NCT03347318 2026-03-19
PROFILING
Fondazione del Piemonte per l'Oncologia
Active not recruiting
Clinical Trials
7 trialsNCT07018622 2026-03-11
DAPA-ARMOR
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase 2 Recruiting
NCT07417501 2026-02-18
Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification
Tongji Hospital
Phase 2 Not yet recruiting
NCT06651593 2026-02-17
Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07407985 2026-02-12
GK01IIT-TZ03
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Active not recruiting
NCT04627740 2026-01-20
Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors
Xinqiao Hospital of Chongqing
Phase 1/2 Completed
NCT07351903 2026-01-20
GUARDIAN-02
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Recruiting